Pharmacokinetics and disposition of nanomedicine using biodegradable PEG/PCL polymers as drug carriers

Current Drug Metabolism

Volumn 13, Issue 4, 2012, Pages 338-353

  Wang, Yujun ^a   Gou, Maling ^a   Gong, Changyang ^a   Wang, Cheng ^a   Qian, Yong Zhi ^a,b   Lin, Yun Feng ^a,b   Luo, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Biodegradation; Long circulation; Micelles; PCL; PEG; Release; Target

Indexed keywords

AMPHOPHILE; ANDROSTANOLONE; ARGINYLGLYCYLASPARTIC ACID; COPOLYMER; CREMOPHOR; CYCLOSPORIN A; DOCETAXEL; DOXORUBICIN; DRUG CARRIER; FLUOROURACIL; FOLIC ACID; HONOKIOL; HYALURONIC ACID; INDOMETACIN; MACROGOL; MACROGOL 400; MANNOSE; NANOPARTICLE; NC 1900; ORIDONIN; PACLITAXEL; POLY(ETHYLENE GLYCOL CO EPSILON CAPROLACTONE); POLYCAPROLACTONE; POLYMACON; POLYSORBATE 80; RAPAMYCIN; RETINOIC ACID; SUPERPARAMAGNETIC IRON OXIDE; THIOCTIC ACID; TRANSFERRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AREA UNDER THE CURVE; ARTICLE; BIODEGRADABILITY; CARDIOVASCULAR SYSTEM; CIRCULATION TIME; CRITICAL MICELLE CONCENTRATION; DISTRIBUTION VOLUME; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; ENCAPSULATION; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; NANOMEDICINE; NONHUMAN; SUSTAINED DRUG RELEASE; TARGET ORGAN;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; MICELLES; NANOMEDICINE; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 84860625420     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012800166490     Document Type: Article

References (186)

1. Uhrich K.E.; Cannizzaro, S.M.; Langer, R.S.; Shakesheff, K.M. Polymeric systems for controlled drug release. Chem. Rev., 1999, 99(11), 3181-3198. (Pubitemid 129583051)
2. Carr C.; Ng, J.; Wigmore, T. The side effects of chemotherapeutic agents. Curr. Anaesth. Crit. Care, 2008, 19(2), 70-79. (Pubitemid 351437124)
3. Raschi E.; Vasina, V.; Ursino, M.G.; Boriani, G.; Martoni, A.; De Ponti, F. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacology & Therapeutics, 2010, 125(2), 196-218.
4. Moghimi S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev., 2001, 53(2), 283-318. (Pubitemid 32476118)
5. Knop K.; Mingotaud, A.F.; El-Akra, N.; Violleau, F.; Souchard, J.P. Monomeric pheophorbide(a)-containing poly(ethyleneglycolb- epsilon-caprolactone) micelles for photodynamic therapy. Photochem. Photobiol. Sci., 2009, 8(3), 396-404.
6. Hsieh M.F.; Cuong, N.V.; Chen, C.H.; Chen, Y.T.; Yeh, J.M. Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon- caprolactone)-graft-2- hydroxyethyl cellulose for doxorubicin delivery. J. Nanosci. Nanotechnol., 2008, 8(5), 2362-2368.
7. Blanco E.; Bey, E.A.; Dong, Y.; Weinberg, B.D.; Sutton, D.M.; Boothman, D.A.; Gao, J.[beta]-lapachone-containing peg-pla polymer micelles as novel nanotherapeutics against nqo1- overexpressing tumor cells. J. Control. Release, 2007, 122(3), 365- 374. (Pubitemid 47404665)
8. Yoo H.S.; Park, T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated plga-peg block copolymer. J. Control. Release, 2001, 70(1-2), 63-70. (Pubitemid 32144793)
9. Shim W.S.; Kim, J.H.; Park, H.; Kim, K.; Chan Kwon, I.; Lee, D.S. Biodegradability and biocompatibility of a ph- and thermosensitive hydrogel formed from a sulfonamide-modified poly(epsilon-caprolactone-co-lactide)- poly(ethylene glycol)- poly(epsilon-caprolactone-co-lactide) block copolymer. Biomaterials, 2006, 27(30), 5178-5185. (Pubitemid 44080294)
10. Yamamoto Y.; Nagasaki, Y.; Kato, Y.; Sugiyama, Y.; Kataoka, K. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge. J. Control. Release, 2001, 77(1-2), 27-38. (Pubitemid 33022613)
11. Shi R.; Chen, D.F.; Liu, Q.Y.; Wu, Y.; Xu, X.C.; Zhang, L.Q.; Tian, W. Recent advances in synthetic bioelastomers. Int. J. Mol. Sci., 2009, 10(10), 4223-4256.
12. Ping P.; Wang, W.S.; Chen, X.S.; Jing, X.B. Poly(epsiloncaprolactone) polyurethane and its shape-memory property. Biomacromolecules, 2005, 6(2), 587-592. (Pubitemid 40467797)
13. da Silva G.R.; Cunha, A.D.; Ayres, E.; Orefice, R.L. Effect of the macromolecular architecture of biodegradable polyurethanes on the controlled delivery of ocular drugs. J. Mater. Sci-Mater. M., 2009, 20(2), 481-487.
14. Sinha V.R.; Bansal, K.; Kaushik, R.; Kumria, R.; Trehan, A. Polyepsilon- caprolactone microspheres and nanospheres: An overview. Int. J. Pharmaceut., 2004, 278(1), 1-23. (Pubitemid 38670433)
15. He C.L.; Sun, J.R.; Zhao, T.; Hong, Z.K.; Zhuang, X.L.; Chen, X.S.; Jing, X.B. Formation of a unique crystal morphology for the poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymer. Biomacromolecules, 2006, 7(1), 252-258. (Pubitemid 43154501)
16. Zhang J.; Wang, L.Q.; Wang, H.J.; Tu, K.H. Micellization phenomena of amphiphilic block copolymers based on methoxy poly(ethylene glycol) and either crystalline or amorphous poly(caprolactone-b-lactide). Biomacromolecules, 2006, 7(9), 2492-2500. (Pubitemid 44530485)
17. Hua C.; Dong, C.M. Synthesis, characterization, effect of architecture on crystallization of biodegradable poly(epsiloncaprolactone) b-poly(ethylene oxide) copolymers with different arms and nanoparticles thereof. J. Biomed. Mater. Res. A, 2007, 82A(3), 689-700. (Pubitemid 47258583)
18. Letchford K.; Zastre, J.; Liggins, R.; Burt, H. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers. Colloids Surf. B Biointerfaces, 2004, 35(2), 81-91. (Pubitemid 38595460)
19. Wei X.W.; Gong, C.Y.; Shi, S.A.; Fu, S.Z.; Men, K.; Zeng, S.; Zheng, X.L.; Gou, M.L.; Chen, L.J.; Qiu, L.Y.; Qian, Z.Y. Selfassembled honokiol-loaded micelles based on poly(epsiloncaprolactone)- poly(ethylene glycol)- poly(epsilon-caprolactone) copolymer. Int. J. Pharmaceut., 2009, 369(1-2), 170-175.
20. Sachl R.; Uchman, M.; Matejicek, P.; Prochazka, K.; Stepanek, M.; Spirkova, M. Preparation and characterization of selfassembled nanoparticles formed by poly(ethylene oxide)-blockpoly( epsilon-caprolactone) copolymers with long poly(epsiloncaprolactone) blocks in aqueous solutions. Langmuir, 2007, 23(6), 3395-3400. (Pubitemid 46450179)
21. Jette K.K.; Law, D.; Schmitt, E.A.; Kwon, G.S. Preparation and drug loading of poly(ethylene glycol)-block-poly(epsiloncaprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharmaceut. Res., 2004, 21(7), 1184-1191. (Pubitemid 38954202)
22. He C.; Sun, J.; Deng, C.; Zhao, T.; Deng, M.; Chen, X.; Jing, X. Study of the synthesis, crystallization, and morphology of poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers. Biomacromolecules, 2004, 5(5), 2042-2047. (Pubitemid 39335248)
23. Cohn D.; Stern, T.; Gonzalez, M.F.; Epstein, J. Biodegradable poly(ethylene oxide)/poly(epsilon-caprolactone) multiblock copolymers. J. Biomed. Mater. Res., 2002, 59(2), 273-281. (Pubitemid 33126631)
24. Kricheldorf H.R.; Fechner, B.; Shikanov, A.; Domb, A. Polylactones 57. Biodegradable networks based on a b a triblock segments containing poly(ethylene glycol)s-syntheses and drug release properties. Biomacromolecules, 2003, 4(4), 950-955. (Pubitemid 36939463)
25. Cho H.K.; Cho, K.S.; Cho, J.H.; Choi, S.W.; Kim, J.H.; Cheong, I.W. Synthesis and characterization of peo-pcl-peo triblock copolymers: Effects of the pcl chain length on the physical property of w(1)/o/w(2) multiple emulsions. Colloids Surf. B Biointerfaces, 2008, 65(1), 61-68.
26. Gou M.L.; Qian, Z.Y.; Wang, H.; Tang, Y.B.; Huang, M.J.; Kan, B.; Wen, Y.J.; Dai, M.; Li, X.Y.; Gong, C.Y.; Tu, M.J. Preparation and characterization of magnetic poly(epsilon-caprolactone)- poly(ethylene glycol)-poly(epsilon- caprolactone) microspheres. J. Mater. Sci. Mater. Med., 2008, 19(3), 1033-1041. (Pubitemid 351337488)
27. Ferruti P.; Mancin, I.; Ranucci, E.; De Felice, C.; Latini, G.; Laus, M. Polycaprolactone-poly(ethylene glycol) multiblock copolymers as potential substitutes for di(ethylhexyl) phthalate in flexible poly(vinyl chloride) formulations. Biomacromolecules, 2003, 4(1), 181-188. (Pubitemid 36575641)
28. Cometa S.; Chiellini, F.; Bartolozzi, I.; Chiellini, E.; De Giglio, E.; Sabbatini, L. Surface segregation assessment in poly(epsiloncaprolactone)- poly(ethylene glycol) multiblock copolymer films. Macromol. Biosci., 2010, 10(3), 317-327.
29. Aryal S.; Prabaharan, M.; Pilla, S.; Gong, S. Biodegradable and biocompatible multi-arm star amphiphilic block copolymer as a carrier for hydrophobic drug delivery. Int. J. Biol. Macromol., 2009, 44(4), 346-352.
30. Quaglia F.; Ostacolo, L.; Nese, G.; Canciello, M.; De Rosa, G.; Ungaro, F.; Palumbo, R.; La Rotonda, M.I.; Maglio, G. Micelles based on amphiphilic pcl-peo triblock and star-shaped diblock copolymers: Potential in drug delivery applications. J. Biomed. Mater. Res. A., 2008, 87(3), 563-574.
31. Wang F.; Bronich, T.K.; Kabanov, A.V.; Rauh, R.D.; Roovers, J. Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon- caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug. Chem., 2005, 16(2), 397- 405. (Pubitemid 40388216)
32. Yang Y.; Hua, C.; Dong, C.M. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendronlike poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly (epsilon-caprolactone) triblock copolymers. Biomacromolecules, 2009, 10(8), 2310-2318.
33. Xiong M.P.; Yanez, J.A.; Remsberg, C.M.; Ohgami, Y.; Kwon, G.S.; Davies, N.M.; Forrest, M.L. Formulation of a geldanamycin prodrug in mpeg-b-pcl micelles greatly enhances tolerability and pharmacokinetics in rats. J. Control. Release, 2008, 129(1), 33-40.
34. Park E.K.; Kim, S.Y.; Lee, S.B.; Lee, Y.M. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J. Control. Release, 2005, 109(1-3), 158-168. (Pubitemid 41737262)
35. Gou M.; Zheng, X.; Men, K.; Zhang, J.; Zheng, L.; Wang, X.; Luo, F.; Zhao, Y.; Zhao, X.; Wei, Y.; Qian, Z. Poly(epsiloncaprolactone)/ poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: Preparation, characterization, and application in doxorubicin delivery. J. Phys. Chem. B., 2009, 113(39), 12928- 12933.
36. Hsu S.H.; Tang, C.M.; Lin, C.C. Biocompatibility of poly(epsiloncaprolactone)/ poly(ethylene glycol) diblock copolymers with nanophase separation. Biomaterials, 2004, 25(25), 5593-5601.
37. Huang Y.N.; Gao, H.; Gou, M.L.; Ye, H.X.; Liu, Y.K.; Gao, Y.; Peng, F.; Qian, Z.Y.; Cen, X.B.; Zhao, Y.L. Acute toxicity and genotoxicity studies on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanomaterials. Mutat. Res-Gen. Tox. En., 2010, 696(2), 101-106.
38. Wang X.H.; Kan, B.; Wang, Y.J.; Dong, P.W.; Shi, S.A.; Guo, G.; Zhao, Y.L.; Luo, F.; Zhao, X.; Wei, Y.Q.; Qian, Z.Y. Safety evaluation of amphiphilic three-armed star-shaped copolymer micelles. J. Pharm. Sci-Us., 2010, 99(6), 2830-2838.
39. Kim S.Y.; Lee, Y.M. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsiloncaprolactone) as novel anticancer drug carriers. Biomaterials, 2001, 22(13), 1697-1704. (Pubitemid 32564958)
40. Kim S.Y.; Lee, Y.M.; Baik, D.J.; Kang, J.S. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Biomaterials, 2003, 24(1), 55-63. (Pubitemid 35300203)
41. Fang F.; Gong, C.Y.; Dong, P.W.; Fu, S.Z.; Gu, Y.C.; Guo, G.; Zhao, X.; Wei, Y.Q.; Qian, Z.Y. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon- caprolactone)-poly(ethylene glycol)- poly(epsilon-caprolactone) copolymer. Biomed. Mater., 2009, 4(2), 025002.
42. Vandermeulen G.; Rouxhet, L.; Arien, A.; Brewster, M.E.; Preat, V. Encapsulation of amphotericin b in poly(ethylene glycol)-blockpoly( epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int. J. Pharmaceut., 2006, 309(1-2), 234-240. (Pubitemid 43129487)
43. Shuai X.T.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J.M. Micellar carriers based on block copolymers of poly(e-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release, 2004, 98(3), 415-426. (Pubitemid 39093952)
44. Mizutani M.; Matsuda, T. Photocurable liquid biodegradable copolymers: In vitro hydrolytic degradation behaviors of photocured films of coumarin-endcapped poly(epsiloncaprolactone- co-trimethylene carbonate). Biomacromolecules, 2002, 3(2), 249-255. (Pubitemid 34257142)
45. Wei X.W.; Gong, C.Y.; Gou, M.Y.; Fu, S.Z.; Guo, Q.F.; Shi, S.; Luo, F.; Guo, G.; Qiu, L.Y.; Qian, Z.Y. Biodegradable poly(epsilon-caprolactone)- poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharmaceut., 2009, 381(1), 1-18.
46. Jia W.J.; Gu, Y.C.; Gou, M.L.; Dai, M.; Li, X.Y.; Kan, B.; Yang, J.L.; Song, Q.F.; Wei, Y.Q.; Qian, Z.Y. Preparation of biodegradable polycaprolactone/poly (ethylene glycol)/polycaprolactone (pcec) nanoparticles. Drug Deliv., 2008, 15(7), 409-416.
47. Cho H.J.; An, J.H. The effect of epsilon-caproyl/d,l-lactyl unit composition on the hydrolytic degradation of poly(d,l-lactide-ran epsilon-caprolactone)-poly(ethylene glycol)-poly(d,l-lactide-ranepsilon- caprolactone). Biomaterials, 2006, 27(4), 544-552.
48. Li S.M.; Garreau, H.; Vert, M.; Petrova, T.; Manolova, N.; Rashkov, I. Hydrolytic degradation of poly(oxyethylene)-poly- (epsilon-caprolactone) multiblock copolymers. J. Appl. Polym. Sci., 1998, 68(6), 989-998.
49. Rice M.A.; Sanchez-Adams, J.; Anseth, K.S. Exogenously triggered, enzymatic degradation of photopolymerized hydrogels with polycaprolactone subunits: Experimental observation and modeling of mass loss behavior. Biomacromolecules, 2006, 7(6), 1968-1975. (Pubitemid 43985121)
50. Wang Z.X.; Wang, S.G.; Guidoin, R.; Marois, Y.; Zhang, Z. In vitro homogeneous and heterogeneous degradation of poly(epsiloncaprolactone/ polyethylene glycol/l-lactide): The absence of autocatalysis and the role of enzymes. J. Biomed. Mater. Res. A, 2006, 79A(1), 6-15. (Pubitemid 44452849)
51. Mochizuki M.; Hirano, M.; Kanmuri, Y.; Kudo, K.; Tokiwa, Y. Hydrolysis of polycaprolactone fibers by lipase - effects of draw ratio on enzymatic degradation. J. Appl. Polym. Sci., 1995, 55(2), 289-296.
52. Carstens M.G.; van Nostrum, C.F.; Verrijk, R.; De Leede, L.G.J.; Crommelin, D.J.A.; Hennink, W.E. A mechanistic study on the chemical and enzymatic degradation of peg-oligo(epsiloncaprolactone) micelles. J. Pharm. Sci-Us., 2008, 97(1), 506-518.
53. Tatai L.; Moore, T.G.; Adhikari, R.; Malherbe, F.; Jayasekara, R.; Griffiths, I.; Gunatillake, P.A. Thermoplastic biodegradable polyurethanes: The effect of chain extender structure on properties and in-vitro degradation. Biomaterials, 2007, 28(36), 5407-5417 (Pubitemid 47599639)
54. Li S.M.; Garreau, H.; Pauvert, B.; McGrath, J.; Toniolo, A.; Vert, M. Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol). Biomacromolecules, 2002, 3(3), 525-530. (Pubitemid 34567456)
55. Herold D.A.; Keil, K.; Bruns, D.E. Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem. Pharmacol., 1989, 38(1), 73-76. (Pubitemid 19029156)
56. Gan Z.H.; Liang, Q.Z.; Zhang, J.; Jing, X.B. Enzymatic degradation of poly(epsilon-caprolactone) film in phosphate buffer solution containing lipases. Polym. Degrad. Stabil., 1997, 56(2), 209-213. (Pubitemid 127381750)
57. Gan Z.H.; Yu, D.H.; Zhong, Z.Y.; Liang, Q.Z.; Jing, X.B. Enzymatic degradation of poly(epsilon-caprolactone)/poly(dllactide) blends in phosphate buffer solution. Polymer, 1999, 40(10), 2859-2862.
58. Wu C.; Jim, T.F.; Gan, Z.; Zhao, Y.; Wang, S. A heterogeneous catalytic kinetics for enzymatic biodegradation of poly(epsiloncaprolactone) nanoparticles in aqueous solution. Polymer, 2000, 41(10), 3593-3597. (Pubitemid 30116860)
59. Persenaire O.; Alexandre, M.; Degee, P.; Dubois, P. Mechanisms and kinetics of thermal degradation of poly(epsilon-caprolactone). Biomacromolecules, 2001, 2(1), 288-294. (Pubitemid 32707504)
60. Lin W.J.; Chang, K.L. Degradation of pcl-mpeg diblock copolymer in rat plasma. J. Biomed. Mater. Res. A, 2008, 85A(3), 692-698.
61. Huang M.H.; Li, S.M.; Hutmacher, D.W.; Coudane, J.; Vert, M. Degradation characteristics of poly(epsilon-caprolactone)-based copolymers and blends. J. Appl. Polym. Sci., 2006, 102(2), 1681- 1687. (Pubitemid 44518345)
62. Yu G.Q.; Zhang, Y.; Shi, X.D.; Li, Z.S.; Gan, Z.H. Surface property and in vitro biodegradation of microspheres fabricated by poly(epsilon-caprolactone- b-ethylene oxide) diblock copolymers. J. Biomed. Mater. Res. A, 2008, 84A(4), 926-939. (Pubitemid 351295003)
63. Hu Y.; Zhang, L.Y.; Cao, Y.; Ge, H.X.; Jiang, X.Q.; Yang, C.Z. Degradation behavior of poly(epsilon-caprolactone)-bpoly( ethylene glycol)-b-poly(epsilon-caprolactone) micelles in aqueous solution. Biomacromolecules, 2004, 5(5), 1756-1762. (Pubitemid 39335211)
64. Huang M.H.; Li, S.M.; Hutmacher, D.W.; Schantz, J.T.; Vacanti, C.A.; Braud, C.; Vert, M. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol). J. Biomed. Mater. Res. A, 2004, 69A(3), 417-427. (Pubitemid 38668167)
65. Dwan'isa J.P.L.; Rouxhet, L.; Brewster, M.E.; Preat, V.; Arien, A. Spontaneously self-assembled micelles from poly(ethylene glycol)- b-poly(epsilon-caprolactone-co-trimethylene carbonate) for drug solubilization. Pharmazie, 2008, 63(3), 235-240. (Pubitemid 351449936)
66. Woodward S.C.; Brewer, P.S.; Moatamed, F.; Schindler, A.; Pitt, C.G. The intracellular degradation of poly(epsilon-caprolactone). J. Biomed. Mater. Res., 1985, 19(4), 437-444.
67. Sun H.; Mei, L.; Song, C.; Cui, X.; Wang, P. The in vivo degradation, absorption and excretion of pcl-based implant. Biomaterials, 2006, 27(9), 1735-1740. (Pubitemid 41759467)
68. Fox M.E.; Szoka, F.C.; Frechet, J.M. Soluble polymer carriers for the treatment of cancer: The importance of molecular architecture. Acc. Chem. Res., 2009, 42(8), 1141-1151.
69. Mohanty C.; Acharya, S.; Mohanty, A.K.; Dilnawaz, F.; Sahoo, S.K. Curcumin-encapsulated mepeg/pcl diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy. Nanomedicine-Uk, 2010, 5(3), 433-449.
70. Savic R.; Azzam, T.; Eisenberg, A.; Maysinger, D. Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: A fluorogenic-based approach. Langmuir, 2006, 22(8), 3570-3578. (Pubitemid 43672524)
71. Forrest M.L.; Won, C.Y.; Malick, A.W.; Kwon, G.S. In vitro release of the mtor inhibitor rapamycin from poly(ethylene glycol)- b-poly(epsilon- caprolactone) micelles. J. Control. Release, 2006, 110(2), 370-377. (Pubitemid 41827491)
72. Gong C.Y.; Wei, X.W.; Wang, X.H.; Wang, Y.J.; Guo, G.; Mao, Y.Q.; Luo, F.; Qian, Z.Y. Biodegradable self-assembled peg-pclpeg micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology, 2010, 21(21), -.
73. Li R.T.; Li, X.L.; Xie, L.; Ding, D.; Hu, Y.; Qian, X.P.; Yu, L.X.; Ding, Y.T.; Jiang, X.Q.; Liu, B.R. Preparation and evaluation of peg-pcl nanoparticles for local tetradrine delivery. Int. J. Pharmaceut., 2009, 379(1), 158-166.
74. Zhang Y.; Zhuo, R.X. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone. Biomaterials, 2005, 26(33), 6736-6742. (Pubitemid 41021767)
75. Hu Y.; Xie, J.W.; Tong, Y.W.; Wang, C.H. Effect of peg conformation and particle size on the cellular uptake efficiency of nanoparticles with the hepg2 cells. Journal of Controlled Release, 2007, 118(1), 7-17. (Pubitemid 46283099)
76. Sutton D.; Wang, S.H.; Nasongkla, N.; Gao, J.M.; Dormidontova, E.E. Doxorubicin and beta-lapachone release and interaction with micellar core materials: Experiment and modeling. Exp. Biol. Med., 2007, 232(8), 1090-1099. (Pubitemid 47358192)
77. Yang X.Q.; Zhu, B.; Dong, T.A.; Pan, P.J.; Shuai, X.T.; Inoue, Y.S. Interactions between an anticancer drug and polymeric micelles based on biodegradable polyesters. Macromol. Biosci., 2008, 8(12), 1116-1125.
78. Jeong Y.I.; Kang, M.K.; Sun, H.S.; Kang, S.S.; Kim, H.W.; Moon, K.S.; Lee, K.J.; Kim, S.H.; Jung, S. All-trans-retinoic acid release from core-shell type nanoparticles of poly (epsilon-caprolactone)/ poly (ethylene glycol) diblock copolymer. Int. J. Pharmaceut., 2004, 273(1-2), 95-107. (Pubitemid 38317044)
79. Kim S.Y.; Shin, I.L.G.; Lee, Y.M.; Cho, C.S.; Sung, Y.K. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. Ii. Micelle formation and drug release behaviours. J. Control. Release, 1998, 51(1), 13-22. (Pubitemid 28064641)
80. Ge H.X.; Hu, Y.; Jiang, X.Q.; Cheng, D.M.; Yuan, Y.Y.; Bi, H.; Yang, C.Z. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)- poly(ethylene oxide)-poly(epsilon- caprolactone) amphiphilic triblock copolymer micelles. J. Pharm. Sci-Us., 2002, 91(6), 1463- 1473. (Pubitemid 34633962)
81. Yu Z.J.; Liu, L.J. Microwave-assisted synthesis of poly(epsiloncaprolactone) poly(ethylene glycol)-poly(epsilon-caprolactone) triblock co-polymers and use as matrices for sustained delivery of ibuprofen taken as model drug. J. Biomat. Sci-Polym. E., 2005, 16(8), 957-971.
82. Allen C.; Han, J.N.; Yu, Y.S.; Maysinger, D.; Eisenberg, A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J. Control. Release, 2000, 63(3), 275-286.
83. Ryu J.G.; Jeong, Y.I.; Kim, I.S.; Lee, J.H.; Nah, J.W.; Kim, S.H. Clonazepam release from core-shell type nanoparticles of poly(epsilon- caprolactone)/poly(ethylene glycol)/poly(epsiloncaprolactone) triblock copolymers. Int. J. Pharmaceut., 2000, 200(2), 231-242.
84. He Y.Y.; Zhang, Y.; Gu, C.H.; Dai, W.F.; Lang, M.D. Micellar carrier based on methoxy poly(ethylene glycol)-blockpoly( epsilon-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery. J. Mater. Sci-Mater. M., 2010, 21(2), 567-574.
85. Katz J.S.; Levine, D.H.; Davis, K.P.; Bates, F.S.; Hammer, D.A.; Burdick, J.A. Membrane stabilization of biodegradable polymersomes. Langmuir, 2009, 25(8), 4429-4434.
86. Xu Y.M.; Meng, F.H.; Cheng, R.; Zhong, Z.Y. Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin. Macromol. Biosci., 2009, 9(12), 1254-1261.
87. Xu P.S.; Van Kirk, E.A.; Li, S.Y.; Murdoch, W.J.; Ren, J.; Hussain, M.D.; Radosz, M.; Shen, Y.Q. Highly stable core-surfacecrosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloid Surface B., 2006, 48(1), 50-57.
88. Xu P.S.; Tang, H.D.; Li, S.Y.; Ren, J.; Van Kirk, E.; Murdoch, W.J.; Radosz, M.; Shen, Y.Q. Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers. Biomacromolecules, 2004, 5(5), 1736-1744. (Pubitemid 39335209)
89. Shuai X.T.; Merdan, T.; Schaper, A.K.; Xi, F.; Kissel, T. Corecross- linked polymeric micelles as paclitaxel carriers. Bioconjugate Chem., 2004, 15(3), 441-448. (Pubitemid 38657848)
90. Iijima M.; Nagasaki, Y.; Okada, T.; Kato, M.; Kataoka, K. Corepolymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules, 1999, 32(4), 1140-1146.
91. Lee H.J.; Choi, S.H.; Nah, M.H.; Lim, J.O.; Lee, I.K. Fabrication of an alpha-lipoic acid-eluting poly-(d,l-lactide-co-caprolactone) cuff for the inhibition of neointimal formation. Exp. Mol. Med., 2009, 41(1), 25-32.
92. Sun H.L.; Guo, B.N.; Cheng, R.; Meng, F.H.; Liu, H.Y.; Zhong, Z.Y. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials, 2009, 30(31), 6358-6366.
93. Das G.S.; Rao, G.H.R.; Wilson, R.F.; Chandy, T. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv., 2000, 7(3), 129-138.
94. Forrest M.L.; Yanez, J.A.; Remsberg, C.M.; Ohgami, Y.; Kwon, G.S.; Davies, N.M. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsiloncaprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity. Pharm. Res-Dord., 2008, 25(1), 194- 206.
95. Kim S.Y.; Lee, Y.M.; Shin, H.J.; Kang, J.S. Indomethacin-loaded methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanosphere: Pharmacokinetic characteristics of indomethacin in the normal sprague-dawley rats. Biomaterials, 2001, 22(14), 2049-2056. (Pubitemid 32567644)
96. Lin W.J.; Chen, Y.C.; Lin, C.C.; Chen, C.F.; Chen, J.W. Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies. J. Biomed. Mater. Res. B., 2006, 77B(1), 188-194.
97. Yanez J.A.; Forrest, M.L.; Ohgami, Y.; Kwon, G.S.; Davies, N.M. Pharmacometrics and delivery of novel nanoformulated peg-bpoly( epsilon-caprolactone) micelles of rapamycin. Cancer Chemoth. Pharm., 2008, 61(1), 133-144. (Pubitemid 47512635)
98. Aliabadi H.M.; Brocks, D.R.; Lavasanifar, A. Polymeric micelles for the solubilization and delivery of cyclosporine a: Pharmacokinetics and biodistribution. Biomaterials, 2005, 26(35), 7251- 7259. (Pubitemid 41133577)
99. Liu J.B.; Zeng, F.Q.; Allen, C. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. Eur. J. Pharm. Biopharm., 2007, 65(3), 309-319.
100. Letchford K.; Liggins, R.; Burt, H. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: Theoretical and experimental data and correlations. J. Pharm. Sci., 2008, 97(3), 1179-1190.
101. Mosqueira V.C.F.; Legrand, P.; Gulik, A.; Bourdon, O.; Gref, R.; Labarre, D.; Barratt, G. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel peg-modified nanocapsules. Biomaterials, 2001, 22(22), 2967-2979. (Pubitemid 32768704)
102. Zhu Z.X.; Anacker, J.L.; Ji, S.X.; Hoye, T.R.; Macosko, C.W.; Prud'homme, R.K. Formation of block copolymer-protected nanoparticles via reactive impingement mixing. Langmuir, 2007, 23(21), 10499-10504. (Pubitemid 47623222)
103. Kumar V.; Prud'Homme, R.K. Thermodynamic limits on drug loading in nanoparticle cores. J. Pharm. Sci-Us., 2008, 97(11), 4904-4914.
104. Lin W.J.; Wang, C.L.; Chen, Y.C. Comparison of two pegylated copolymeric micelles and their potential as drug carriers. Drug Deliv., 2005, 12(4), 223-227.
105. Gou M.L.; Zheng, X.L.; Men, K.; Zhang, J.; Wang, B.L.; Lv, L.; Wang, X.H.; Zhao, Y.L.; Luo, F.; Chen, L.J.; Zhao, X.; Wei, Y.Q.; Qian, Z.Y. Self-assembled hydrophobic honokiol loaded mpeg-pcl diblock copolymer micelles. Pharm. Res-Dord., 2009, 26(9), 2164-2173.
106. Mohanty A.K.; Dilnawaz, F.; Mohanty, C.; Sahoo, S.K. Etoposideloaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy. Drug Deliv., 2010, 17(5), 330- 342.
107. Richter A.; Olbrich, C.; Krause, M.; Kissel, T. Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery. Int. J. Pharmaceut., 2010, 389(1-2), 244-253.
108. Aliabadi H.M.; Mahmud, A.; Sharifabadi, A.D.; Lavasanifar, A. Micelles of methoxy poly(ethylene oxide)-b-poly(epsiloncaprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine a. J. Control. Release, 2005, 104(2), 301- 311. (Pubitemid 40724931)
109. Ma Z.S.; Haddadi, A.; Molavi, O.; Lavasanifar, A.; Lai, R.; Samuel, J. Micelles of poly(ethylene oxide)-b-poly(epsiloncaprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res. A, 2008, 86A(2), 300-310. (Pubitemid 351969628)
110. Diab R.; Hamoudeh, M.; Boyron, O.; Elaissari, A.; Fessi, H. Microencapsulation of cytarabine using poly(ethylene glycol)- poly(epsilon-caprolactone) diblock copolymers as surfactant agents. Drug Dev. Ind. Pharm., 2010, 36(4), 456-469.
111. Liu J.; Zahedi, P.; Zeng, F.Q.; Allen, C. Nano-sized assemblies of a peg-docetaxel conjugate as a formulation strategy for docetaxel. J. Pharm. Sci-Us., 2008, 97(8), 3274-3290.
112. Parrish B.; Emrick, T. Soluble camptothecin derivatives prepared by click cycloaddition chemistry on functional aliphatic polyesters. Bioconjugate Chem., 2007, 18(1), 263-267. (Pubitemid 46146018)
113. Zhang X.F.; Li, Y.X.; Chen, X.S.; Wang, X.H.; Xu, X.Y.; Liang, Q.Z.; Hu, J.L.; Jing, X.B. Synthesis and characterization of the paclitaxel/mpeg-pla block copolymer conjugate. Biomaterials, 2005, 26(14), 2121-2128.
114. Sobczak M.; Witkowska, E.; Oledzka, E.; Kolodziejski, W. Synthesis and structural analysis of polyester prodrugs of norfloxacin. Molecules, 2008, 13(1), 96-106.
115. Sobczak M. Synthesis and characterization of polyester conjugates of ciprofloxacin. Eur. J. Med. Chem., 2010.
116. Gou P.F.; Zhu, W.P.; Shen, Z.Q. Synthesis, self-assembly, and drug-loading capacity of well-defined cyclodextrin-centered drugconjugated amphiphilic a(14)b(7) miktoarm star copolymers based on poly(epsilon- caprolactone) and poly(ethylene glycol). Biomacromolecules, 2010, 11(4), 934-943.
117. Mikhail A.S.; Allen, C. Poly(ethylene glycol)-b-poly(epsiloncaprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: Synthesis, characterization, and the influence of the drug on micelle morphology. Biomacromolecules, 2010, 11(5), 1273-1280.
118. Adams M.L.; Kwon, G.S. Relative aggregation state and hemolytic activity of amphotericin b encapsulated by poly(ethylene oxide)- block-poly(n-hexyl-l- aspartamide)-acyl conjugate micelles: Effects of acyl chain length. J. Control. Release, 2003, 87(1-3), 23-32. (Pubitemid 36255445)
119. Jackson J.K.; Zhang, X.C.; Llewellen, S.; Hunter, W.L.; Burt, H.M. The characterization of novel polymeric paste formulations for intratumoral delivery. Int. J. Pharmaceut., 2004, 270(1-2), 185- 198. (Pubitemid 38077099)
120. Zhang W.L.; Li, Y.L.; Liu, L.X.; Sun, Q.Q.; Shuai, X.T.; Zhu, W.; Chen, Y.M. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties. Biomacromolecules, 2010, 11(5), 1331-1338.
121. Du J.Z.; Tang, L.Y.; Song, W.J.; Shi, Y.; Wang, J. Evaluation of polymeric micelles from brush polymer with poly(epsiloncaprolactone)- b-poly(ethylene glycol) side chains as drug carrier. Biomacromolecules, 2009, 10(8), 2169-2174.
122. Peng C.L.; Shieh, M.J.; Tsai, M.H.; Chang, C.C.; Lai, P.S. Selfassembled star-shaped chlorin-core poly(c-caprolactone)- poly(ethylene glycol) diblock copolymer micelles for dual chemophotodynamic therapies. Biomaterials, 2008, 29(26), 3599-3608.
123. Zhang L.Y.; Hu, Y.; Jiang, X.Q.; Yang, C.Z.; Lu, W.; Yang, Y.H. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-bpeg- b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J. Control. Release, 2004, 96(1), 135-148. (Pubitemid 38438496)
124. Hu Y.; Jiang, X.Q.; Ding, Y.; Zhang, L.Y.; Yang, C.Z.; Zhang, J.F.; Chen, J.N.; Yang, Y.H. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)- polylactide amphiphilic copolymer nanoparticles. Biomaterials, 2003, 24(13), 2395-2404. (Pubitemid 36434059)
125. Ge H.X.; Hu, Y.; Yang, S.C.; Jiang, X.Q.; Yang, C.Z. Preparation, characterization, and drug release behaviors of drug-loaded epsilon- caprolactone/l-lactide copolymer nanoparticles. J. Appl. Polym. Sci., 2000, 75(7), 874-882. (Pubitemid 30527128)
126. Peters T., Jr. Serum albumin. Adv. Protein Chem., 1985, 37, 161- 245.
127. Dong Y.; Feng, S.S. Methoxy poly(ethylene glycol)-poly(lactide) (mpeg-pla) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 2004, 25(14), 2843-2849. (Pubitemid 38201309)
128. Photos P.J.; Bacakova, L.; Discher, B.; Bates, F.S.; Discher, D.E. Polymer vesicles in vivo: Correlations with peg molecular weight. J. Control. Release, 2003, 90(3), 323-334. (Pubitemid 36859964)
129. Shan X.; Yuan, Y.; Liu, C.; Tao, X.; Sheng, Y.; Xu, F. Influence of peg chain on the complement activation suppression and longevity in vivo prolongation of the pcl biomedical nanoparticles. Biomed Microdevices, 2009, 11(6), 1187-1194.
130. Cha E.J.; Kim, J.E.; Ahn, C.H. Stabilized polymeric micelles by electrostatic interactions for drug delivery system. Eur. J. Pharm. Sci., 2009, 38(4), 341-346.
131. Blume G.; Cevc, G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta, 1993, 1146(2), 157-168. (Pubitemid 23084758)
132. Zhao J.; Liu, C.S.; Yuan, Y.; Tao, X.Y.; Shan, X.Q.; Sheng, Y.; Wu, F. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials, 2007, 28(7), 1414-1422. (Pubitemid 44959037)
133. Allen C.; Dos Santos, N.; Gallagher, R.; Chiu, G.N.C.; Shu, Y.; Li, W.M.; Johnstone, S.A.; Janoff, A.S.; Mayer, L.D.; Webb, M.S.; Bally, M.B. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Bioscience Rep., 2002, 22(2), 225- 250. (Pubitemid 35222733)
134. Lee S.H.; Zhang, Z.P.; Feng, S.S. Nanoparticles of poly(lactide) - tocopheryl polyethylene glycol succinate (pla-tpgs) copolymers for protein drug delivery. Biomaterials, 2007, 28(11), 2041-2050. (Pubitemid 46188359)
135. Carrstensen H.; Muller, R.H.; Muller, B.W. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model
136. Moghimi S.M.; Hunter, A.C. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm. Res., 2001, 18(1), 1-8. (Pubitemid 32299615)
137. Gref R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Muller, R.H. 'stealth' corona-core nanoparticles surface modified by polyethylene glycol (peg): Influences of the corona (peg chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B. Biointerfaces, 2000, 18(3-4), 301-313. (Pubitemid 30479870)
138. Semple S.C.; Chonn, A.; Cullis, P.R. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Deliver. Rev., 1998, 32(1- 2), 3-17. (Pubitemid 28277172)
139. Mosqueira V.C.F.; Legrand, P.; Morgat, J.L.; Vert, M.; Mysiakine, E.; Gref, R.; Devissaguet, J.P.; Barratt, G. Biodistribution of longcirculating peg-grafted nanocapsules in mice: Effects of peg chain length and density. Pharm. Res-Dord., 2001, 18(10), 1411-1419. (Pubitemid 32977246)
140. Gombotz W.R.; Wang, G.H.; Horbett, T.A.; Hoffman, A.S. Protein adsorption to poly(ethylene oxide) surfaces. J. Biomed. Mater. Res., 1991, 25(12), 1547-1562.
141. Bergstrom K.; Holmberg, K.; Safranj, A.; Hoffman, A.S.; Edgell, M.J.; Kozlowski, A.; Hovanes, B.A.; Harris, J.M. Reduction of fibrinogen adsorption on peg-coated polystyrene surfaces. J. Biomed. Mater. Res., 1992, 26(6), 779-790.
142. Bergstrom K.; Osterberg, E.; Holmberg, K.; Hoffman, A.S.; Schuman, T.P.; Kozlowski, A.; Harris, J.H. Effects of branching and molecular weight of surface-bound poly(ethylene oxide) on protein rejection. J. Biomater. Sci. Polym. Ed., 1994, 6(2), 123-132.
143. Yamaoka T.; Tabata, Y.; Ikada, Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci., 1994, 83(4), 601-606. (Pubitemid 24222392)
144. Steels B.M.; Leermakers, F.A.M.; Haynes, C.A. Analysis of compression of polymer mushrooms using self-consistent field theory. J. Chromatogr. B., 2000, 743(1-2), 31-40. (Pubitemid 30408224)
145. Steels B.M.; Koska, J.; Haynes, C.A. Analysis of brush-particle interactions using self-consistent-field theory. J. Chromatogr. B., 2000, 743(1-2), 41-56. (Pubitemid 30408225)
146. Szleifer I. Protein adsorption on surfaces with grafted polymers: A theoretical approach. Biophys. J., 1997, 72(2), 595-612. (Pubitemid 27044869)
147. Vittaz M.; Bazile, D.; Spenlehauer, G.; Verrecchia, T.; Veillard, M.; Puisieux, F.; Labarre, D. Effect of peo surface density on longcirculating pla-peo nanoparticles which are very low complement activators. Biomaterials, 1996, 17(16), 1575-1581. (Pubitemid 26289744)
148. Gref R.; Domb, A.; Quellec, P.; Blunk, T.; Muller, R.H.; Verbavatz, J.M.; Langer, R. The controlled intravenous delivery of drugs using peg-coated sterically stabilized nanospheres. Adv. Drug Deliver. Rev., 1995, 16(2-3), 215-233.
149. Fox M.E.; Szoka, F.C.; Frechet, J.M.J. Soluble polymer carriers for the treatment of cancer: The importance of molecular architecture. Accounts Chem. Res., 2009, 42(8), 1141-1151.
150. Jain R.K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev., 1987, 6(4), 559-593.
151. Matsumura Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 1986, 46(12 Pt 1), 6387-6392. (Pubitemid 17221789)
152. Feng N.; Wu, P.; Li, Q.; Mei, Y.; Shi, S.; Yu, J.; Xu, J.; Liu, Y.; Wang, Y. Oridonin-loaded poly(epsilon-caprolactone)- poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma. J. Drug Target., 2008, 16(6), 479-485. (Pubitemid 352015816)
153. Yokoyama M.; Okano, T.; Sakurai, Y.; Fukushima, S.; Okamoto, K.; Kataoka, K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J. Drug Target., 1999, 7(3), 171-186. (Pubitemid 30028961)
154. Li X.; Li, R.; Qian, X.; Ding, Y.; Tu, Y.; Guo, R.; Hu, Y.; Jiang, X.; Guo, W.; Liu, B. Superior antitumor efficiency of cisplatinloaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur. J. Pharm. Biopharm., 2008, 70(3), 726-734.
155. Bolderman R.W.; Bruin, P.; Hermans, J.J.; Boerakker, M.J.; Dias, A.A.; van der Veen, F.H.; Maessen, J.G. Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch. J. Thorac. Cardiovasc. Surg., 2010.
156. Danhier F.; Vroman, B.; Lecouturier, N.; Crokart, N.; Pourcelle, V.; Freichels, H.; Jerome, C.; Marchand-Brynaert, J.; Feron, O.; Preat, V. Targeting of tumor endothelium by rgd-grafted plgananoparticles loaded with paclitaxel. J. Control. Release, 2009, 140(2), 166-173.
157. Nasongkla N.; Shuai, X.; Ai, H.; Weinberg, B.D.; Pink, J.; Boothman, D.A.; Gao, J. Crgd-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem. Int. Ed. Engl., 2004, 43(46), 6323-6327. (Pubitemid 40029462)
158. Nasongkla N.; Bey, E.; Ren, J.; Ai, H.; Khemtong, C.; Guthi, J.S.; Chin, S.F.; Sherry, A.D.; Boothman, D.A.; Gao, J. Multifunctional polymeric micelles as cancer-targeted, mri-ultrasensitive drug delivery systems. Nano Lett., 2006, 6(11), 2427-2430. (Pubitemid 46076928)
159. Garinot M.; Fievez, V.; Pourcelle, V.; Stoffelbach, F.; des Rieux, A.; Plapied, L.; Theate, I.; Freichels, H.; Jerome, C.; Marchand-Brynaert, J.; Schneider, Y.J.; Preat, V. Pegylated plga-based nanoparticles targeting m cells for oral vaccination. J. Control. Release, 2007, 120(3), 195-204. (Pubitemid 47061488)
160. Pourcelle V.; Devouge, S.; Garinot, M.; Preat, V.; Marchand-Brynaert, J. Pcl-peg-based nanoparticles grafted with grgds peptide: Preparation and surface analysis by xps. Biomacromolecules, 2007, 8, 3977-398
161. Daniels T.R.; Delgado, T.; Helguera, G.; Penichet, M.L. The transferrin receptor part ii: Targeted delivery of therapeutic agents into cancer cells. Clin. Immunol., 2006, 121(2), 159-176. (Pubitemid 44572972)
162. Yang X.Q.; Grailer, J.J.; Pilla, S.; Steeber, D.A.; Gong, S.Q. Tumor-targeting, ph-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy. Bioconjugate Chem., 2010, 21(3), 496-504.
163. Rieger J.; Stoffelbach, F.; Cui, D.; Imberty, A.; Lameignere, E.; Putaux, J.L.; Jerome, R.; Jerome, C.; Auzely-Velty, R. Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: Synthesis, characterization, and interaction with a bacterial lectin. Biomacromolecules, 2007, 8(9), 2717-2725. (Pubitemid 47516921)
164. Wang Y.C.; Liu, X.Q.; Sun, T.M.; Xiong, M.H.; Wang, J. Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery. J. Control. Release, 2008, 128(1), 32-40.
165. Jeong Y.I.; Seo, S.J.; Park, I.K.; Lee, H.C.; Kang, I.C.; Akaike, T.; Cho, C.S. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int. J. Pharm., 2005, 296(1-2), 151-161. (Pubitemid 40693384)
166. Gref R.; Couvreur, P.; Barratt, G.; Mysiakine, E. Surfaceengineered nanoparticles for multiple ligand coupling. Biomaterials, 2003, 24(24), 4529-4537. (Pubitemid 36960147)
167. Yadav A.K.; Mishra, P.; Jain, S.; Mishra, A.K.; Agrawal, G.P. Preparation and characterization of ha-peg-pcl intelligent corecorona nanoparticles for delivery of doxorubicin. J. Drug Target., 2008, 16(6), 464-478. (Pubitemid 352015815)
168. Dinauer N.; Balthasar, S.; Weber, C.; Kreuter, J.; Langer, K.; von Briesen, H. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary t-lymphocytes. Biomaterials, 2005, 26(29), 5898-5906. (Pubitemid 40803459)
169. Park E.K.; Lee, S.B.; Lee, Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials, 2005, 26(9), 1053-1061. (Pubitemid 39208991)
170. Leamon C.P.; Reddy, J.A. Folate-targeted chemotherapy. Adv. Drug Deliver. Rev., 2004, 56(8), 1127-1141. (Pubitemid 38496512)
171. Lu Y.J.; Sega, E.; Leamon, C.P.; Low, P.S. Folate receptor-targeted immunotherapy of cancer: Mechanism and therapeutic potential. Adv. Drug Deliver. Rev., 2004, 56(8), 1161-1176. (Pubitemid 38496513)
172. Choi H.; Choi, S.R.; Zhou, R.; Kung, H.F.; Chen, I.W. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad. Radiol., 2004, 11(9), 996-1004. (Pubitemid 39220809)
173. Chen S.; Zhang, X.Z.; Cheng, S.X.; Zhuo, R.X.; Gu, Z.W. Functionalized amphiphilic hyperbranched polymers for targeted drug delivery. Biomacromolecules, 2008, 9(10), 2578-2585.
174. Hong G.B.; Yuan, R.X.; Liang, B.L.; Shen, J.; Yang, X.Q.; Shuai, X.T. Folate functionalized polymeric micelle as hepatic carcinomatargeted, mri-ultrasensitive delivery system of antitumor drugs. Biomed. Microdevices, 2008, 10(5), 693-700.
175. Yang X.Q.; Deng, W.J.; Fu, L.W.; Blanco, E.; Gao, J.M.; Quan, D.P.; Shuai, X.T. Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator fg020326. J. Biomed. Mater. Res. A, 2008, 86A(1), 48-60. (Pubitemid 351799487)
176. Chang S.S.; Reuter, V.E.; Heston, W.D.W.; Bander, N.H.; Grauer, L.S.; Gaudin, P.B. Five different anti-prostate-specific membrane antigen (psma) antibodies confirm psma expression in tumorassociated neovasculature. Cancer Research, 1999, 59(13), 3192- 3198. (Pubitemid 29316022)
177. Farokhzad O.C.; Cheng, J.J.; Teply, B.A.; Sherifi, I.; Jon, S.; Kantoff, P.W.; Richie, J.P.; Langer, R. Targeted nanoparticleaptamer bioconjugates for cancer chemotherapy in vivo. P. Natl. Acad. Sci. USA, 2006, 103(16), 6315-6320.
178. Lupold S.E.; Rodriguez, R. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen. Mol. Cancer Ther., 2004, 3(5), 597-603. (Pubitemid 39193738)
179. Chandran S.S.; Banerjee, S.R.; Mease, R.C.; Pomper, M.G.; Denmeade, S.R. Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (psma). Cancer Biol. Ther., 2008, 7(6), 978- 986.
180. Cho C.S.; Kobayashi, A.; Takei, R.; Ishihara, T.; Maruyama, A.; Akaike, T. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials, 2001, 22(1), 45-51.
181. Liang H.F.; Chen, C.T.; Chen, S.C.; Kulkarni, A.R.; Chiu, Y.L.; Chen, M.C.; Sung, H.W. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials, 2006, 27(9), 2051- 2059. (Pubitemid 41759499)
182. Liang H.F.; Yang, T.F.; Huang, C.T.; Chen, M.C.; Sung, H.W. Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by hepg2 cells. J. Control. Release, 2005, 105(3), 213-225.
183. Ashwell G.; Harford, J. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem., 1982, 51, 531-554.
184. McGreal E.P.; Miller, J.L.; Gordon, S. Ligand recognition by antigen-presenting cell c-type lectin receptors. Curr. Opin. Immunol., 2005, 17(1), 18-24. (Pubitemid 40094008)
185. Pourcelle V.; Freichels, H.; Stoffelbach, F.; Auzely-Velty, R.; Jerome, C.; Marchand-Brynaert, J. Light induced functionalization of pcl-peg block copolymers for the covalent immobilization of biomolecules. Biomacromolecules, 2009, 10(4), 966-974.
186. Pang Z.; Lu, W.; Gao, H.; Hu, K.; Chen, J.; Zhang, C.; Gao, X.; Jiang, X.; Zhu, C. Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26. J. Control. Release, 2008, 128(2), 120-127.